Pharma stocks: Nomura gives ‘Buy’ to Lupin remains ‘Neutral’ on others
Source: Business Standard 4 min read Last Updated : Sep 16 2024 | 11:02 AM IST The Indian pharmaceutical giants are taking a halt in filing new drug applications, with new filings lowest in the past 19 years, says a latest report by Japanese brokerage firm, Nomura. However, this is not concerning the…
